Monitoring of Benign Thyroid Nodules

Rationale for Monitoring

The International Journal of Surgery recommends regular monitoring of benign thyroid nodules to detect potential changes in size, characteristics, or rare malignant transformation, with a risk of approximately 0.3-0.9% over 5 years 1, 2, 3

The American College of Surgeons recommends first follow-up evaluation at 1 month after initial diagnosis, and subsequent assessments at 3, 6, and 12 months during the first year 2
Annual follow-up is recommended for benign nodules after the first year, as suggested by the International Journal of Surgery and Praxis Medical Insights 2, 3
Follow-up should include thyroid and neck ultrasound to assess nodule size and characteristics, as recommended by the International Journal of Surgery and Praxis Medical Insights 1, 3
Volume reduction rate (VRR) should be calculated using the formula: [(Preoperative nodule volume – current nodule volume) × 100]/preoperative volume (%) 1

Changes in nodule size and volume should be monitored, as recommended by the International Journal of Surgery and Praxis Medical Insights 1, 3
Development of suspicious ultrasound features (microcalcifications, central hypervascularity, irregular margins) should be monitored, as suggested by Praxis Medical Insights 3
Presence of compression symptoms (difficulty swallowing, breathing, or voice changes) should be assessed, as recommended by the International Journal of Surgery 1
Thyroid function tests should be performed if abnormal at baseline or if nodule characteristics change, as recommended by the International Journal of Surgery and Praxis Medical Insights 1, 2

Long-term monitoring is necessary, as changes can occur even after many years, as recommended by the International Journal of Surgery 1
The Chinese guidelines recommend annual follow-up indefinitely for benign nodules, as reported by the International Journal of Surgery 1, 2